30. J.C. Roberts, S.L. Newmyer, J.A. Mercer-Smith, S.A. Schreyer, D.K. Lavallee, Labeling
antibodies with copper radionuclides using N-4-nitrobenzyl-5-(4-carboxyphenyl)-10, 15,
20-tris (4-sulfophenyl) porphine. Int. J. Rad. Appl. Instrum. A. 40(9), 775–781 (1989)
31. Y. Fazaeli, A.R. Jalilian, M.M. Amini, M. Aboudzadeh, S. Feizi, A. Rahiminezhad et al.,
Preparation, nano purification, quality control and labeling optimization of (
64
Cu)-5, 10, 15,
20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent.
J. Radioanal. Nucl. Chem. 295(1), 255–263 (2013)
32. J. Shi, T. Liu, J. Chen, D. Green, D. Jaffray, B.C. Wilson et al., Transforming a targeted
porphyrin theranostic agent into a PET imaging probe for cancer. Theranostics 1, 363–370
(2011)
33. H. Huang, J.F. Lovell, Advanced functional nanomaterials for theranostics. Adv. Funct.
Mater. 27(2), 1603524 (2017)
34. D. Luo, K.A. Carter, J.F. Lovell, Nanomedical engineering: shaping future nanomedicines.
Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7(2), 169–188 (2015)
35. S.M. Janib, A.S. Moses, J.A. MacKay, Imaging and drug delivery using theranostic
nanoparticles. Adv. Drug Deliv. Rev. 62(11), 1052–1063 (2010)
36. X. Ma, Y. Zhao, X.-J. Liang, Theranostic nanoparticles engineered for clinic and
pharmaceutics. Acc. Chem. Res. 44(10), 1114–1122 (2011)
37. T.W. Liu, T.D. MacDonald, J. Shi, B.C. Wilson, G. Zheng, Intrinsically copper-64-labeled
organic nanoparticles as radiotracers. Angew. Chem. Intl. Ed. Engl. 51(52), 13128–13131
(2012)
38. T.W. Liu, T.D. MacDonald, C.S. Jin, J.M. Gold, R.G. Bristow, B.C. Wilson et al., Inherently
multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate
tumors and micrometastases. ACS Nano 7(5), 4221–4232 (2013)
39. J. Rieffel, U. Chitgupi, J.F. Lovell, Recent advances in higher-order, multimodal, biomedical
imaging agents. Small 11(35), 4445–4461 (2015)
40. H. Huang, R. Hernandez, J. Geng, H. Sun, W. Song, F. Chen et al., A porphyrin-PEG
polymer with rapid renal clearance. Biomaterials 76, 25–32 (2016)
41. Y. Zhang, D. Wang, S. Goel, B. Sun, U. Chitgupi, J. Geng et al., Surfactant-stripped frozen
pheophytin micelles for multimodal gut imaging. Adv. Mater. 28(38), 8524–8530 (2016)
42. J. Rieffel, F. Chen, J. Kim, G. Chen, W. Shao, S. Shao et al., Hexamodal imaging with
porphyrin-phospholipid-coated upconversion nanoparticles. Adv. Mater. 27(10), 1785–1790
(2015)
43. Y. Li, Lin T-y, Y. Luo, Q. Liu, W. Xiao, W. Guo et al., A smart and versatile theranostic
nanomedicine platform based on nanoporphyrin. Nat. Commun. 5, 4712 (2014)
44. L. Feng, L. Cheng, Z. Dong, D. Tao, T.E. Barnhart, W. Cai et al., Theranostic liposomes with
hypoxia-activated prodrug to effectively destruct hypoxic tumors post photodynamic therapy.
ACS Nano. (2016)
45. Y. Fazaeli, A.R. Jalilian, M.M. Amini, A. Rahiminejad-kisomi, S. Rajabifar, F. Bolourinovin
et al., Preparation and preliminary evaluation of (
67
Ga)-tetra phenyl porphyrin complexes as
possible imaging agents. J. Radioanal. Nucl. Chem. 288(1), 17–24 (2011)
46. K. Sasaki, N. Yumita, R. Nishigaki, I. Sakata, S. Nakajima, Umemura Si. Pharmacokinetic
study of a gallium-porphyrin photo- and sono-sensitizer, ATX-70, in tumor-bearing mice.
Cancer Sci. 92(9), 989–995 (2001)
47. Y. Fazaeli, A.R. Jalilian, M.M. Amini, K. Ardaneh, A. Rahiminejad, F. Bolourinovin et al.,
Development of a
68
Ga-fluorinated porphyrin complex as a possible PET imaging agent.
Nucl. Med. Mol. Imaging 46(1), 20–26 (2012)
48. F. Zoller, P.J. Riss, F.-P. Montforts, D.K. Kelleher, E. Eppard, F. Rösch, Radiolabelling and
preliminary evaluation of 68 Ga-tetrapyrrole derivatives as potential tracers for PET. Nucl.
Med. Biol. 40(2), 280–288 (2013)
49. S. Jurisson, D. Berning, W. Jia, D. Ma, Coordination compounds in nuclear medicine. Chem.
Rev. (U. S.) 93(3), 11371156 (1993)
3 Porphyrin and Phthalocyanine Radiolabeling
75
antibodies with copper radionuclides using N-4-nitrobenzyl-5-(4-carboxyphenyl)-10, 15,
20-tris (4-sulfophenyl) porphine. Int. J. Rad. Appl. Instrum. A. 40(9), 775–781 (1989)
31. Y. Fazaeli, A.R. Jalilian, M.M. Amini, M. Aboudzadeh, S. Feizi, A. Rahiminezhad et al.,
Preparation, nano purification, quality control and labeling optimization of (
64
Cu)-5, 10, 15,
20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent.
J. Radioanal. Nucl. Chem. 295(1), 255–263 (2013)
32. J. Shi, T. Liu, J. Chen, D. Green, D. Jaffray, B.C. Wilson et al., Transforming a targeted
porphyrin theranostic agent into a PET imaging probe for cancer. Theranostics 1, 363–370
(2011)
33. H. Huang, J.F. Lovell, Advanced functional nanomaterials for theranostics. Adv. Funct.
Mater. 27(2), 1603524 (2017)
34. D. Luo, K.A. Carter, J.F. Lovell, Nanomedical engineering: shaping future nanomedicines.
Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7(2), 169–188 (2015)
35. S.M. Janib, A.S. Moses, J.A. MacKay, Imaging and drug delivery using theranostic
nanoparticles. Adv. Drug Deliv. Rev. 62(11), 1052–1063 (2010)
36. X. Ma, Y. Zhao, X.-J. Liang, Theranostic nanoparticles engineered for clinic and
pharmaceutics. Acc. Chem. Res. 44(10), 1114–1122 (2011)
37. T.W. Liu, T.D. MacDonald, J. Shi, B.C. Wilson, G. Zheng, Intrinsically copper-64-labeled
organic nanoparticles as radiotracers. Angew. Chem. Intl. Ed. Engl. 51(52), 13128–13131
(2012)
38. T.W. Liu, T.D. MacDonald, C.S. Jin, J.M. Gold, R.G. Bristow, B.C. Wilson et al., Inherently
multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate
tumors and micrometastases. ACS Nano 7(5), 4221–4232 (2013)
39. J. Rieffel, U. Chitgupi, J.F. Lovell, Recent advances in higher-order, multimodal, biomedical
imaging agents. Small 11(35), 4445–4461 (2015)
40. H. Huang, R. Hernandez, J. Geng, H. Sun, W. Song, F. Chen et al., A porphyrin-PEG
polymer with rapid renal clearance. Biomaterials 76, 25–32 (2016)
41. Y. Zhang, D. Wang, S. Goel, B. Sun, U. Chitgupi, J. Geng et al., Surfactant-stripped frozen
pheophytin micelles for multimodal gut imaging. Adv. Mater. 28(38), 8524–8530 (2016)
42. J. Rieffel, F. Chen, J. Kim, G. Chen, W. Shao, S. Shao et al., Hexamodal imaging with
porphyrin-phospholipid-coated upconversion nanoparticles. Adv. Mater. 27(10), 1785–1790
(2015)
43. Y. Li, Lin T-y, Y. Luo, Q. Liu, W. Xiao, W. Guo et al., A smart and versatile theranostic
nanomedicine platform based on nanoporphyrin. Nat. Commun. 5, 4712 (2014)
44. L. Feng, L. Cheng, Z. Dong, D. Tao, T.E. Barnhart, W. Cai et al., Theranostic liposomes with
hypoxia-activated prodrug to effectively destruct hypoxic tumors post photodynamic therapy.
ACS Nano. (2016)
45. Y. Fazaeli, A.R. Jalilian, M.M. Amini, A. Rahiminejad-kisomi, S. Rajabifar, F. Bolourinovin
et al., Preparation and preliminary evaluation of (
67
Ga)-tetra phenyl porphyrin complexes as
possible imaging agents. J. Radioanal. Nucl. Chem. 288(1), 17–24 (2011)
46. K. Sasaki, N. Yumita, R. Nishigaki, I. Sakata, S. Nakajima, Umemura Si. Pharmacokinetic
study of a gallium-porphyrin photo- and sono-sensitizer, ATX-70, in tumor-bearing mice.
Cancer Sci. 92(9), 989–995 (2001)
47. Y. Fazaeli, A.R. Jalilian, M.M. Amini, K. Ardaneh, A. Rahiminejad, F. Bolourinovin et al.,
Development of a
68
Ga-fluorinated porphyrin complex as a possible PET imaging agent.
Nucl. Med. Mol. Imaging 46(1), 20–26 (2012)
48. F. Zoller, P.J. Riss, F.-P. Montforts, D.K. Kelleher, E. Eppard, F. Rösch, Radiolabelling and
preliminary evaluation of 68 Ga-tetrapyrrole derivatives as potential tracers for PET. Nucl.
Med. Biol. 40(2), 280–288 (2013)
49. S. Jurisson, D. Berning, W. Jia, D. Ma, Coordination compounds in nuclear medicine. Chem.
Rev. (U. S.) 93(3), 11371156 (1993)
3 Porphyrin and Phthalocyanine Radiolabeling
75